A detailed history of Claro Advisors LLC transactions in Incyte Corp stock. As of the latest transaction made, Claro Advisors LLC holds 3,698 shares of INCY stock, worth $272,616. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,698
Holding current value
$272,616
% of portfolio
0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

BUY
$65.08 - $83.38 $240,665 - $308,339
3,698 New
3,698 $255,000
Q1 2019

May 10, 2019

SELL
$63.56 - $88.17 $1,080 - $1,498
-17 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $994 - $1,188
17 New
17 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Claro Advisors LLC Portfolio

Follow Claro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.